8
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of GM-CSF in the management of chronic mucocutaneous candidiasis

, , , &
Pages 289-292 | Received 01 Feb 1999, Accepted 16 Apr 1999, Published online: 12 Jul 2009

References

  • Charles H, Kirkpatrick C H. Chronic mucocutaneous candidiasis. J Am Acad Dermatol 1994; 31(3/2)S14–S17
  • Corbeel L, Ceuppens J L, Van den Berghe G, et al. Immunological observations before and after successful treatment of chronic mucocutaneous candidiasis with ketoconazole and transfer factor. Eur J Pediatr 1984; 143(1)45–8
  • Miksiewicz Wasilewska H, Grubek Jaworska A, Plucinska M, et al. Transfer factor (TFd). Part IV. Transfer factor in mucocutaneous candidiasis treatment. Mater Med Pol 1981; 13(2)108–12
  • Kirkpatrick C H, Rich R R, Graw R G, et al. Treatment of chronic mucocutaneous moniliasis by immunologic reconstitution. Clin Exp Immunol 1971; 9: 733–48
  • Kirkpatrick C H, Greenberg L E. Treatment of chronic mucocutaneous candidiasis with transfer factor. Immune regulators in transfer factor, A Kahn, C H Kirkpatrick, N O Hill. Academic Press, New York 1979; 547–62
  • Trevisan G, Kokelj F, Perticarari S, et al. Chronic candidiasis: treatment with bovine thymic extract. Case report. G Ital Dermatol Venereol 1982; 117(3)161–4
  • Sander E, Prolla G, Marques A R, et al. Reversal by interleukin-2 of alopecia universalis, mucocutaneous candidiasis, and sexual impotence in a patient with malignant thymoma. J Natl Cancer Inst 1993; 85(8)673, (letter)
  • Pollizzi B, Origgi L, Zuccaro G, Math P, Scorza R. Successful treatment with cimetidine and zinc sulphate in chronic mucocutaneous candidiasis. Am J Med Soc 1996; 311(4)189–90
  • Valdimarson H, Higgs J M, Wells R S, et al. Immune abnormalities associated with chronic mucocutaneous candidiasis. Cell Immunol 1973; 6: 348–61
  • Shahar E, Kriboy N, Pollack S. White cell enhancement in the treatment of severe candidosis. Lancet 1995; 346: 974–5
  • Djeu J Y. Cytokine and antifungal immunity. Adv Exp Med Biol 1992; 319: 217–23
  • Mitsuyasu R T, Golde D W. Clinical uses of GM-CSF. Hematol Oncol Clin North Am 1989; 3(3)411–25
  • Calderone R, Sturtevant J. Macrophage interactions with Candida. Immunol Ser 1994; 60: 505–15
  • Scarffe H. Emerging uses for GM-CSF. Eur J Cancer 1991; 27(11)1493–504

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.